Community-Based Physical Activity Programs Help to Improve in HRQOL in Underserved Breast Cancer Survivors

Article

Breast cancer survivors who are minorities or medically underserved appear to experience a benefit in health-related quality of life after taking part in a community-based physical activity program.

A community-based physical activity program was shown to provide minority and medically underserved breast cancer survivors with improvements to mental and physical wellbeing, according to a study published in Cancer.

An improvement of mental and physical quality of life from baseline (P <.01) was observed among patients who participated in the program. Notably, patients achieved an improvement in physical functioning, with investigators reporting an increase in ability to do sit-to-stand repetitions from a mean of 12.5 at baseline to 14.9 at follow-up (P <.01). Additionally, patients’ 6-minute walk distance increased from a mean of 428 m at baseline to 470 m at follow-up.

“Although community-based exercise programs for cancer survivors exist in some areas, they are structured exercise programs in which participants are required to visit a gym-like environment and exercise under supervision. The [Active Living After Cancer; ALAC] program is an innovative approach to increasing activity that promotes home-based exercise and encourages lifestyle changes by setting personalized and achievable goals,” investigators wrote.

A total of 427 patients were invited to partake in the program. Investigators reported a recruitment rate of 45%, a completion rate of 74%, and a retention rate of 68%. A total of 34 ALAC groups were launched, 32 of which were completed. Twenty-six groups met at clinics/health care organizations, 5 groups met at community organizations, and 3 groups met at churches. Of the 12 sessions, patients attended a mean of 7.4 sessions. In particular, patients who completed baseline and follow-up assessments attended a mean of 9.4 sessions.

At the 12-week follow-up, 127 patients reported more moderate to vigorous physical activity at 344.6 minutes per week compared with 172.8 minutes per week at baseline. Additionally, a statistically significant improvement in the physical domain was noted from 45.2 at baseline to 47.5 at follow-up (P <.01). Similar benefit was noted in the mental domain from 48.3 at baseline to 49.8 at follow-up (P <.01).

For those who completed the program, 73% were able to identify at least 2 community resources for survivors of breast cancer, and 96% were able to recognize a minimum of 2 benefits from physical activity. In order to increase activity, the majority of patients utilized behavioral strategies such as setting goals (68%), self-monitoring (84%), self-rewarding (64%), friends and family support (71%), and problem solving (64%). Of these 3 points, 83% of patients implemented at least 2 of them.

Of the patients who partook in the program, 98% were satisfied, 97% said the program helped them to be more physically active, 92% felt better physically, and 83% felt better emotionally. It was also reported that 98% of breast cancer survivors who participated said that they would recommend the ALAC program to other survivors.

Reference

Tami-Maury IM, Liao Y, Rangel ML, et al. Active living after cancer: adaptation and evaluation of a community-based physical activity program for minority and medically underserved breast cancer survivors. Cancer. Published online September 23, 2021. doi:10.1002/cncr.33904

Recent Videos
Social workers and case managers may have access to institutional- or hospital-level grants that can reduce financial toxicity for patients undergoing cancer therapy.
Insurance and distance to a tertiary cancer center were 2 barriers to receiving high-quality breast cancer care, according to Rachel Greenup, MD, MPH.
Antibody-drug conjugates are effective, but strategies such as better understanding the mechanisms of action may lead to enhanced care for patients with cancer. Antibody-drug conjugates are effective, but strategies such as better understanding the mechanisms of action may lead to enhanced care for patients with cancer.
ADCs demonstrate superior efficacy vs chemotherapy but maintain a similar efficacy profile that requires multidisciplinary collaboration to optimally treat.
According to Aditya Bardia, MD, MPH, FASCO, antibody-drug conjugates are slowly replacing chemotherapy as a standard treatment for breast cancer.
Administering oral SERD-based regimens may enhance patients’ quality of life when undergoing treatment for ER-positive, HER2-negative breast cancer.
Gedatolisib-based triplet regimens may be effective among patients with prior endocrine resistance or rapid progression following frontline therapy.
Leading experts in the breast cancer field highlight the use of CDK4/6 inhibitors, antibody-drug conjugates, and other treatment modalities.
Related Content